Gilead Sciences Inc. (GILD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
78.97-1.65 (-2.05%)
As of 11:48 AM EDT. Market open.
People also watch:
CELGBIIBAMGNREGNBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open79.32
Prev Close80.62
Bid79.20 x 700
Ask79.21 x 1400
Day's Range78.86 - 79.88
52wk Range76.67 - 111.11
1y Target EstN/A
Market Cap104.21B
P/E Ratio (ttm)6.93
Beta1.00
Volume5,671,843
Avg Vol (3m)10,627,257
Dividend & Yield1.88 (2.31%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • TheStreet.com1 hour ago

    Jim Cramer -- Gilead Needs to Make an Acquisition

    Investors shouldn't give up on Gilead's Hep. C drug, Cramer says.

  • Barrons.com2 hours ago

    Gilead Sciences: Tired of Waiting

    Leerink's Geoffrey Porges and Bradley Canino cut shares of Gilead Sciences (GILD) to Market Perform from Outperform, arguing that they're "tired of waiting." They explain why: We are downgrading Gilead Sciences today to Market Perform, and reducing our price target from $112 to $94. This sizable change in price target is driven by our updated forecast for the company’s HCV business, about which we have long been cautious but have now turned outright bearish. This lower forecast will inevitably be associated with margin erosion, and we have lowered our EBIT margin forecast by 310-480bps in each year after 2016.

  • TheStreet.com4 hours ago

    Gilead (GILD) Stock Falls on Ratings Downgrade

    Gilead (GILD) stock was down in pre-market trading on Tuesday after Leerink cut its rating on shares to 'market perform.'